The Globostad study OBS15990 eDiary App has been developed for the Prospective Observational Study of adult patients receiving Dupixent for atopic dermatitis.The App will collect eDiary information for subjects registered into this study.*Note: this App requires an activation code and can only be accessed by subjects who are participating in the OBS15990 trial
Show More
What's new in the latest 1.3.1-1
Last updated on Feb 12, 2025
Minor bug fixes and improvements. Install or update to the newest version to check it out!
We use cookies and other technologies on this website to enhance your user experience. By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.